Hints and tips:
Related Special Reports
...Bresch, who joined the company in 1992 as a data-entry clerk, led the group through several multibillion-dollar acquisitions, including takeovers of Sweden’s Meda and the generic drugs business of Abbott Laboratories...
...SoftBank founder predicts WeWork V for Victory Masayoshi Son admitted today he had turned a “blind eye” to governance lapses at WeWork but promised a “sharp V-shaped recovery” for the shared offices provider...
...Idexx said in October that the animal health market had experienced a “V-shaped recovery”....
...She cleaned the general office space, rather than the laboratories, according to her sworn declaration filed in the case....
...Actavis Holdco U.S., Inc.; Actavis Pharma, Inc.; Ascend Laboratories, LLC; Apotex Corp.; Dr....
...One of his touchstones for anti-competitive behaviour is the late 1990s US v Microsoft case, in which the company was found guilty of using its operating system monopoly to stifle competitors like Netscape...
...Qubits v bytes: how quantum computing works Quantum computing taps into the quirky behaviour of sub-atomic particles, which bend our normal understanding of physics....
...He places human embryonic and pluripotent stem cells — that have the potential to grow into nearly every cell of the body — in tiny ‘U’ or ‘V’ shaped dishes in the lab to grow them into different types of...
...Thanks to a series of court rulings since the mid-2000s, such as eBay v MercExchange in 2007, Mayo Collaborative Services v Prometheus Laboratories in 2012 and Alice Corp v CLS Bank in 2014, and the subsequent...
...Mr Loncar says there are some “outrageous” cases of high prices, referencing Mylan’s allergy injector, the Epipen, and the Aids and cancer medicine that brought infamy to Martin Shkreli....
...Lannett Company, which has a market value of around $700m, dropped 19 per cent while Impax Laboratories (market cap $1.3bn) fell 12.4 per cent....
...Mr Saunders says that, in buying Whole Foods, Amazon is also acquiring a larger laboratory for its experiments in bricks-and-mortar retailing, which have multiplied over the past two years — but only on...
...Abbott Laboratories, the US pharmaceuticals group, has agreed to acquire St Jude Medical for $25bn, in the first mega healthcare deal following a three-month lull after last year’s frantic merger and acquisition...
...In February, Mylan closed a $5.6bn deal to acquire certain non-US assets from Abbott Laboratories....
...Abbott Laboratories, the US pharmaceutical and healthcare company, has been preparing a takeover bid for St Jude Medical that was set to value the medical device maker at $25bn, people familiar with the...
...from Abbott Laboratories of the US....
...So would the new Mylan, which said on Monday that it would invert by purchasing European assets from Abbott Laboratories. The geography is dizzying....
...The acquisition will add about $1.9bn of annual revenues to Mylan, according to the company....
...The other India-based generic drugmakers involved in the deal are Cadila Healthcare, Hetero Labs, Mylan Laboratories, Sequent Scientific and Strides Arcolab....
...Mylan Inc, the US generic drug producer, is eyeing the takeover of Swedish rival Meda in a deal that would create a $23bn-plus pharmaceuticals business as the US healthcare industry goes through one of the...
...In another so-called tax inversion, Mylan is to buy Abbot Laboratories’ European business. One pharma deal still in the works is Valeant/Allergan....
...from Abbott Laboratories....
...The Financial Times revealed this week that Mylan was interested in Meda of Sweden but the approach was rebuffed....
...their way out of the laboratory into run-of-the-mill reality....
...Ranbaxy has been serving the US market from a single US facility, Ohm Laboratories....
International Edition